Tenlifine M Tablet (Teneligliptin + Metformin) | Used to Manage Type 2 Diabetes Mellitus in Adults
Tenlifine M Tablet (Teneligliptin + Metformin) is a combination antidiabetic medicine used to manage type 2 diabetes mellitus. Controls fasting and post-meal blood sugar levels by increasing insulin and reducing glucose production.
Product Overview
Tenlifine M Tablet is a high-performance dual-action antidiabetic medication combining two potent blood-glucose-lowering agents: Teneligliptin and Metformin. Tenlifine M Tablet is a combination therapy is specifically designed for the comprehensive management of Type 2 Diabetes Mellitus in patients whose blood sugar levels are not adequately controlled by metformin monotherapy. By targeting multiple pathways of glucose metabolism, it helps achieve stable glycemic control throughout the day.
Product Composition
- Teneligliptin: A third-generation DPP-4 inhibitor (Gliptin).
- Metformin Hydrochloride: A biguanide that acts as an insulin sensitizer.
- Formulation: Typically available in Sustained-Release (SR) or Extended-Release (ER) versions to ensure balanced glucose levels.
- Common Strengths: Teneligliptin 20mg combined with Metformin 500mg or 1000mg.
Product Specifications
| Feature | Specification |
| Drug Category | Oral Hypoglycemic Agent (Combination) |
| Therapeutic Class | Antidiabetic |
| Target Mechanism | DPP-4 Inhibition & Gluconeogenesis Suppression |
| Primary Goal | Reduction of HbA1c levels |
| Storage | Store in a dry place below 30°C |
Mechanism of Action
- Incretin Enhancement: Teneligliptin inhibits the DPP-4 enzyme, which prevents the breakdown of incretin hormones (GLP-1). This stimulates the pancreas to release more insulin and reduces glucagon production in a glucose-dependent manner.
- Hepatic Glucose Suppression: Metformin works primarily in the liver to decrease gluconeogenesis (the production of glucose) and delays intestinal glucose absorption.
- Insulin Sensitivity: Metformin improves peripheral glucose uptake and utilization, making the body's natural insulin work more effectively.
- Postprandial & Fasting Control: This dual mechanism effectively manages both fasting blood sugar (FBS) and post-meal (postprandial) glucose spikes.
Key Benefits
- Comprehensive Glycemic Control: Offers superior efficacy in lowering HbA1c compared to using either medication alone.
- Weight Neutrality: Unlike some other antidiabetic classes, this combination is generally weight neutral or may assist in modest weight management.
- Lower Hypoglycemia Risk: The glucose-dependent action of Teneligliptin significantly reduces the risk of low blood sugar episodes.
- Improved Compliance: Combining two medications into a single fixed-dose tablet simplifies the treatment regimen and improves patient adherence.
- Cardiovascular & Renal Safety: Both components are well-regarded for their safety profiles, with Teneligliptin being particularly useful for patients with varying degrees of renal impairment.
Precautions
Medical supervision
- Use Tenlifine M Tablet (Teneligliptin + Metformin) only under proper medical supervision
- Do not change dose without guidance
- Regular blood sugar monitoring is important
- Long term treatment may need periodic review
Health conditions
| Condition | Precaution |
|---|---|
| Kidney disease | Dose adjustment and monitoring required |
| Liver disease | Use with caution and medical advice |
| Heart disease | Careful monitoring may be needed |
| Pancreatitis history | Use cautiously due to increased risk |
| Alcohol dependence | Higher risk of side effects |
Blood sugar monitoring
- Monitor blood glucose regularly during treatment
- Watch for signs of low blood sugar
- Maintain proper diet and exercise routine
Kidney and liver safety
- Kidney function tests may be required before and during treatment
- Liver monitoring may be needed in long term use
- Report swelling, weakness, or reduced urine output
Digestive precautions
- May cause stomach upset or diarrhea initially
- Taking with food may reduce discomfort
- Maintain proper hydration during treatment
Lifestyle precautions
- Avoid excessive alcohol intake
- Follow diabetic diet and exercise recommendations
- Do not skip meals during therapy
Monitoring advice
- Regular blood sugar and HbA1c tests may be needed
- Report severe abdominal pain, vomiting, or unusual weakness
- Seek medical attention if symptoms worsen
Usage
Tenlifine M Tablet is a precision combination antidiabetic therapy. To achieve optimal glycemic regulation and minimize potential side effects, the medication must be administered in alignment with daily nutritional intake to support the body’s natural metabolic processes.
Dosage and Administration
Following these clinical administration steps is essential for maintaining stable blood glucose levels and ensuring the efficacy of the Sustained-Release (SR) mechanism.
Timing with Meals: This medication should be taken with a meal (usually dinner or breakfast). Taking it with food significantly improves gastric tolerance and reduces the risk of stomach upset associated with Metformin.
Tablet Integrity: The tablet must be swallowed whole with a glass of water. Do not crush, break, or chew the tablet, as this would cause a rapid release of the medication, increasing the risk of side effects and reducing the duration of glucose control.
Consistency: For the best results in lowering HbA1c, take the medication at the same time every day to maintain a steady concentration of Teneligliptin and Metformin in the system.
Hydration: Ensure adequate fluid intake throughout the day to support kidney function while on Metformin therapy.
Avoid Alcohol: It is strongly advised to avoid excessive alcohol consumption while taking Tenlifine M, as it can increase the risk of lactic acidosis and unpredictable blood sugar fluctuations.
Monitoring: Regular monitoring of blood glucose levels (fasting and postprandial) and periodic kidney function tests (e.g., serum creatinine) are recommended.
Missed Dose: If you miss a dose, take it with your next meal unless it is almost time for the following dose. Never take two tablets at once to make up for a forgotten one.
Uses
Tenlifine M Tablet is indicated for the long-term management of metabolic health in adults, specifically targeting the complex requirements of glucose homeostasis.
Primary Therapeutic Uses
Management of Type 2 Diabetes Mellitus: Primary use for patients whose blood sugar is not adequately controlled by lifestyle changes and metformin monotherapy.
Reduction of HbA1c Levels: Targeted to lower long-term average blood sugar levels, helping patients reach their clinical glycemic targets.
Control of Postprandial Glucose: Teneligliptin specifically helps manage the sharp sugar spikes that occur immediately after consuming food.
Regulation of Fasting Blood Sugar: Metformin ensures the liver does not produce excessive glucose during periods of fasting, such as overnight.
Prevention of Diabetic Complications: By maintaining stable glucose levels, it helps reduce the risk of long-term damage to the eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy).
Insulin Sensitization: Helps the body's cells respond more effectively to the insulin already present in the bloodstream.
Weight-Neutral Glycemic Management: Provides a therapeutic option for patients who need to control blood sugar without the weight gain associated with some other classes of antidiabetics.
Side effects
Common side effects
- Nausea
- Diarrhea
- Stomach discomfort
- Headache
- Dizziness
- Weakness or fatigue
Digestive system effects
- Bloating
- Loss of appetite
- Vomiting
- Metallic taste in mouth
- Abdominal pain
Blood sugar related effects
- Low blood sugar when used with other diabetes medicines
- Sweating
- Shakiness
- Increased hunger
- Confusion in some cases
General effects
- Tiredness
- Mild weight changes
- Sleep disturbance
- Reduced energy levels
Serious side effects (rare)
| Serious effect | Possible signs |
|---|---|
| Lactic acidosis | Severe weakness, breathing difficulty, muscle pain |
| Pancreatitis | Severe abdominal pain, vomiting |
| Kidney problems | Reduced urine, swelling, fatigue |
| Severe allergy | Rash, swelling, breathing difficulty |
| Severe low blood sugar | Confusion, fainting, seizures |
Important warning
- Stop use and seek immediate attention if serious symptoms occur
- Monitor for severe abdominal pain, breathing difficulty, or unusual weakness
- Regular blood sugar and kidney function tests may help reduce risks during treatment
FAQs
Q: What is Generic Tenlifine M Tablet used for? A
: Generic Tenlifine M Tablet is used to manage high blood sugar levels in adults with type 2 diabetes mellitus. It helps control both fasting and post-meal blood sugar levels and is used in patients who do not respond adequately to Metformin alone.
Q: How does Generic Tenlifine M Tablet work?
A: Metformin works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's sensitivity to insulin. Teneligliptin works by inhibiting the DPP-4 enzyme, which increases insulin release from the pancreas and reduces glucagon levels that raise blood sugar. Together, they provide better overall control of blood sugar levels.
Q: How should Generic Tenlifine M Tablet be taken?
A: Generic Tenlifine M Tablet should be taken with food, preferably after meals, to reduce the chance of stomach upset. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
Q: What are the common side effects of Generic Tenlifine M Tablet?
A: Common side effects include nausea, vomiting, diarrhoea, stomach pain, headache, respiratory infection, weight gain, sweating, and dizziness. Most side effects are mild and resolve on their own. Consult your doctor if they persist or worsen.
Q: Can Generic Tenlifine M Tablet cause low blood sugar (hypoglycaemia)?
A: Yes, Generic Tenlifine M Tablet may cause hypoglycaemia, especially if you miss or delay meals, drink alcohol, exercise excessively, or take other antidiabetic medicines along with this medicine.
Q: Who should not take Generic Tenlifine M Tablet?
A: Generic Tenlifine M Tablet should not be taken by patients who are allergic to Teneligliptin or Metformin. It is also not recommended for patients with severe kidney or liver disease, heart failure, alcoholism, severe systemic infections, or uncontrolled diabetes.
Q: Can Generic Tenlifine M Tablet be used in children?
A: No, Generic Tenlifine M Tablet is not intended for use in children. It is only recommended for adults with type 2 diabetes mellitus.
Q: Can Generic Tenlifine M Tablet be used during pregnancy?
A: Generic Tenlifine M Tablet is not recommended during pregnancy. Consult your doctor before taking this medicine if you are pregnant or planning to become pregnant, as your doctor will assess the risks and benefits and may recommend alternative treatment.
Q: Is Generic Tenlifine M Tablet safe during breastfeeding?
A: Consult your doctor before taking Generic Tenlifine M Tablet while breastfeeding, as the safety of this combination during breastfeeding has not been fully established.
Q: Can I drink alcohol while taking Generic Tenlifine M Tablet?
A: It is advisable to avoid alcohol while taking Generic Tenlifine M Tablet as alcohol may increase the risk of low blood sugar and lactic acidosis, a rare but serious side effect of Metformin.
Q: Does Generic Tenlifine M Tablet require regular monitoring?
A: Yes, your doctor may regularly monitor your blood sugar levels and kidney function during treatment with Generic Tenlifine M Tablet to ensure the medicine is working effectively and to avoid the risk of unwanted side effects.
Interactions
Diabetes medicines
- Combined use with other antidiabetic medicines may increase risk of low blood sugar
- Blood glucose monitoring is important
- Dose adjustment may be needed
Alcohol
- Excessive alcohol intake may increase risk of side effects
- Can affect blood sugar control
- Avoid heavy alcohol consumption during treatment
Kidney affecting medicines
- Some medicines may increase risk of kidney related side effects
- Kidney function monitoring may be required
- Use cautiously in long term therapy
Steroid medicines
- May increase blood sugar levels
- Effectiveness of diabetes treatment may reduce
- Blood sugar monitoring may be needed
Blood pressure medicines
- Some medicines may enhance glucose lowering effect
- Risk of dizziness or weakness may increase
- Monitoring may be required
Contrast dye procedures
- Certain imaging dyes may affect kidney function
- Temporary interruption of treatment may be advised
- Inform healthcare provider before scans or procedures
General advice
- Inform about all ongoing medicines before use
- Avoid starting or stopping medicines without guidance
- Regular monitoring of blood sugar and kidney function may be needed
| Manufacturer | : | Healing Pharma |
| Trade Name | : | Tenelia |
| Generic Search | : | Teneligliptin |
| Strength | : | 500mg, 1000mg |
Latest Products
